NEW YORK, Sept 25- MannKind Corp shares were among the most actively traded in premarket on Thursday, after the company said it had closed a licensing agreement with Sanofi for the development and commercialization of its inhaled insulin product. MannKind said it will receive a $150 million upfront payment within 10 days of the closing.» Read More
LONDON, July 22- ARM Holdings, the British company whose processor designs power Apple's and Samsung's smartphones, posted a 9 percent rise in second-quarter profit, helped by strong demand to license its technology.
May 19- Ophthotech Corp said it could potentially receive over $1 billion in payments as part of a licensing deal for its experimental eye drug with Novartis AG. Ophthotech's shares rose as much as 29 percent in trading after the bell.
*Working on more tiered pricing after deal with Egypt. LONDON, April 8- Gilead Sciences aims to license its new hepatitis C drug Sovaldi to three or four Indian generic manufacturers to allow sales of the medicine at lower prices in some 60 developing nations.